Loading…
Discounted Drugs for Clinical Trials Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Discounted Drugs for Clinical Trials Act This bill allows researchers to obtain certain high-cost drugs and biologics at discounted prices from manufacturers. Researchers must apply to the Food and Drug Administration for approval; manufacturers must sell the approved quantity of drugs to researchers at the discounted price and are subject to civil actions from researchers for noncompliance.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (1)
2022 · fourth_quarter · Health Issues
1. Patient Protection and Affordable Health Care Act, implementation of provisions regarding high risk insurance pools, implementation of state based health exchanges, eligibility for health insurance premium subsidies, cost sharing subsidies, proposals for special enrollment period 2. Stabilization of Affordable Care Act insurance marketplaces 3. Administration proposals on prescription drug pricing 4. Administration proposals for COVID testing and vaccine distribution 5. S. 779, Protecting Americans with Pre-Existing Conditions Act of 2021, entire bill 6. H.R. 597, Pandemic Treatment Access and Affordability Act of 2021, entire bill 7. Vaccine access under the American Rescue Plan 8. H.R. 7472, The Discounted Drugs for Clinical Trials Act, entire bill 9. S. 4053, The Discounted Drugs for Clinical Trials Act, entire bill 10. H.R. 7474, The Pharmaceutical Research and Transparency Act, entire bill 11. S. 4034, The Pharmaceutical Research and Transparency Act, entire bill 12. H.R. 7473, The Generic Substitution Non-Interference Act, entire bill 13. H.R. 7828, Price Relief, Innovation, and Competition for Essential Drugs Act (PRICED Act), entire bill 14. H.R. 5376, Inflation Reduction Act of 2022, provisions relating to premium subsidies under the Affordable Care Act 15. Proposed rulemaking under Section 1557 of the Affordable Care Act regarding Nondiscrimination in Health Programs and Activities 16. Implementation of the No Surprises Act
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $70,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Treasury, Dept of
2022 · third_quarter · Health Issues
1. Patient Protection and Affordable Health Care Act, implementation of provisions regarding high risk insurance pools, implementation of state based health exchanges, eligibility for health insurance premium subsidies, cost sharing subsidies, proposals for special enrollment period 2. Stabilization of Affordable Care Act insurance marketplaces 3. Administration proposals on prescription drug pricing 4. Administration proposals for COVID testing and vaccine distribution 5. S. 779, Protecting Americans with Pre-Existing Conditions Act of 2021, entire bill 6. H.R. 597, Pandemic Treatment Access and Affordability Act of 2021, entire bill 7. Vaccine access under the American Rescue Plan 8. H.R. 7472, The Discounted Drugs for Clinical Trials Act, entire bill 9. S. 4053, The Discounted Drugs for Clinical Trials Act, entire bill 10. H.R. 7474, The Pharmaceutical Research and Transparency Act, entire bill 11. S. 4034, The Pharmaceutical Research and Transparency Act, entire bill 12. H.R. 7473, The Generic Substitution Non-Interference Act, entire bill 13. H.R. 7828, Price Relief, Innovation, and Competition for Essential Drugs Act (PRICED Act), entire bill 14. H.R. 5376, Inflation Reduction Act of 2022, provisions relating to premium subsidies under the Affordable Care Act
Client expense: $70,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · second_quarter · Health Issues
1. Patient Protection and Affordable Health Care Act, implementation of provisions regarding high risk insurance pools, implementation of state based health exchanges, eligibility for health insurance premium subsidies, cost sharing subsidies, proposals for special enrollment period 2. Stabilization of Affordable Care Act insurance marketplaces 3. Administration proposals on prescription drug pricing 4. Administration proposals for COVID testing and vaccine distribution 5. S. 779, Protecting Americans with Pre-Existing Conditions Act of 2021, entire bill 6. H.R. 597, Pandemic Treatment Access and Affordability Act of 2021, entire bill 7. Vaccine access under the American Rescue Plan 8. H.R. 7472, The Discounted Drugs for Clinical Trials Act, entire bill 9. S. 4053, The Discounted Drugs for Clinical Trials Act, entire bill 10. H.R. 7474, The Pharmaceutical Research and Transparency Act, entire bill 11. S. 4034, The Pharmaceutical Research and Transparency Act, entire bill 12. H.R. 7473, The Generic Substitution Non-Interference Act, entire bill 13. H.R. 7828, Price Relief, Innovation, and Competition for Essential Drugs Act (PRICED Act), entire bill
Client expense: $80,000 · Firm income: Not reported
Government targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE